
Abnova (Taiwan) Corporation 4133.TW
4133.TW
Abnova (Taiwan) Corporation 6850.TWO
BiOptic Inc. 6564.TWO
Enimmune corporation 4131.TWO
NeoCore Technology Co., Ltd. 6872.TWO
NaviFUS Corp. 3164.TW
GenMont Biotech Incorporation 4186.TWO
Taiwan Advance Bio-Pharmaceutical Inc. 4197.TWO
Visgeneer Inc. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 4195.TWO
Genomics BioSci & Tech. Co.,Ltd.
Abnova (Taiwan) Corporation 6850.TWO
BiOptic Inc. 6564.TWO
Enimmune corporation 4131.TWO
NeoCore Technology Co., Ltd. 6872.TWO
NaviFUS Corp. 3164.TW
GenMont Biotech Incorporation 4186.TWO
Taiwan Advance Bio-Pharmaceutical Inc. 4197.TWO
Visgeneer Inc. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 4195.TWO
Genomics BioSci & Tech. Co.,Ltd.
Performance
Periode | 4133.TW | 6850.TWO | 6564.TWO | 4131.TWO | 6872.TWO | 3164.TW | 4186.TWO | 4197.TWO | 7427.TWO | 4195.TWO |
---|---|---|---|---|---|---|---|---|---|---|
6M | -4.18 % | 19.08 % | 11.44 % | -3.28 % | -15.03 % | 1.61 % | -0.37 % | 4.48 % | -15.28 % | 38.29 % |
YTD | -13.25 % | 18.66 % | -15.69 % | 1.57 % | -26.80 % | -5.72 % | -13.78 % | 7.47 % | -9.48 % | 30.73 % |
1Y | -15.86 % | 3.30 % | -35.44 % | 8.36 % | -29.83 % | -14.64 % | -12.38 % | 16.93 % | -12.90 % | 41.81 % |
3Y | -22.94 % | 58.89 % | -56.17 % | 47.27 % | -2.49 % | -14.06 % | -11.22 % | 6.06 % | -2.66 % | 35.31 % |
5Y | -64.00 % | 17.24 % | -57.39 % | 51.76 % | -16.36 % | -17.61 % | -49.72 % | -29.77 % | -45.35 % | 43.84 % |
10Y | -16.00 % | 17.24 % | -35.22 % | 69.99 % | -16.36 % | -34.09 % | -48.21 % | -50.89 % | -45.35 % | 39.29 % |
From the beginning | -77.34 % | 17.24 % | -35.22 % | -77.40 % | -16.36 % | 21.32 % | -81.45 % | -65.39 % | -45.35 % | -16.69 % |